待处理
入排:排除
图源:待检查
Correction: Cliniclal benefit of 1-year certolizumab pegol(CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritiswas observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial.
Ann Rheum Dis 81(9) e187
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板